• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE 12-Amino-pyridazino[4',5':3,4]pyrrolo[2,1-a]isoquinolines of general formula I see diagramm : EP0190563,P15,F1 wherein R1 and R2 , which may be identical or different, each represent hydrogen, C3-7 cycloalkyl, C2-5 alkenyl, phenyl (optionally mono- or disubstituted by halogen atoms or methoxy groups), propargyl, a straight-chained or branched, saturated or unsaturated alkyl group with 1 to 5 carbon atoms which may be substituted by hydroxy, alkoxy with 1 to 4 carbon atoms, halogen, NH2 , NH-alkyl with 1 to 2 carbon atoms, N,N-dialkyl with 1 to 2 carbon atoms, NH-acyl with 2 to 4 carbon atoms, cycloalkyl with 3 to 7 carbon atoms, phenyl (optionally substituted by halogen, alkyl with 1 to 2 carbon atoms, alkoxy with 1 to 2 carbon atoms, NH-alkyl with 1 to 2 carbon atoms, N,N-dialkyl with 1 to 2 carbon atoms, NH2 , N-acyl with 2 to 3 carbon atoms), furyl, thienyl, a nitrogen-containing heterocyclic 5- or 6-membered ring which may optionally contain as a further heteroatom an oxygen or sulphur atom (and the ring may optionally be substituted by alkyl with 1 to 4 carbon atoms), or R1 and R2 together with the nitrogen atom represent a 3- to 7-membered ring which may optionally contain as a further heteroatom an oxygen or nitrogen atom [the ring may be optionally substituted by phenyl (C1-4 ) alkyl (this phenyl ring in turn being mono- or disubstituted by halogen atoms or methoxy groups)], or R2 , if R1 represents hydrogen, represents -NH2 , di(C1-2 ) alkylamino, acetonylamino, -NH(C2-3 ) acyl, alkylsulphonyl or alkyloxycarbonyl group with 1 to 3 carbon atoms in the alkyl chain, a isopropylideneimino group see diagramm : EP0190563,P15,F2 or a heterocyclic 5- or 6-membered ring containing a nitrogen atom and optionally containing as a further heteroatom an oxygen, nitrogen or sulphur atom, R3 , R4 and R5 , which may be identical or different, represent hydrogen or alkyl groups with 1 to 4 carbon atoms, R7 and R8 , which may be identical or different, represent hydroxy, alkoxy with 1 to 4 carbon atoms or alkylthio groups with 1 to 4 carbon atoms, and R6 and R9 , which may be identical or different, represent hydrogen, hydroxy, alkoxy with 1 to 4 carbon atoms or alkylthio groups with 1 to 4 carbon atoms or a group see diagramm : EP0190563,P16,F1 wherein R10 represents hydrogen or alkyl with 1 to 4 carbon atoms and R11 represents alkyl with 1 to 4 carbon atoms any such alkyl group being optionally substituted by a hydroxy, methoxy or furfuryl group and physiologically acceptable acid addition salts thereof. 1. Claims for the Contracting State : AT Process for preparing a 12-amino-pyridazino[4',5':3,4]pyrrolo[2,1-a]isoquinoline of general formula see diagramm : EP0190563,P17,F1 wherein R1 and R2 , which may be identical or different, each represent hydrogen, C3-7 cycloalkyl, C2-5 alkenyl, phenyl (optionally mono- or disubstituted by halogen atoms or methoxy groups), propargyl, a straight-chained or branched, saturated or unsaturated alkyl group with 1 to 5 carbon atoms which may be substituted by hydroxy, alkoxy with 1 to 4 carbon atoms, halogen, NH2 , NH-alkyl with 1 to 2 carbon atoms, N,N-dialkyl with 1 to 2 carbon atoms, NH-acyl with 2 to 4 carbon atoms, cycloalkyl with 3 to 7 carbon atoms, phenyl (optionally substituted by halogen, alkyl with 1 to 2 carbon atoms, alkoxy with 1 to 2 carbon atoms, NH-alkyl with 1 to 2 carbon atoms, N,N-dialkyl with 1 to 2 carbon atoms, NH2 , N-acyl with 2 to 3 carbon atoms), furyl, thienyl, a nitrogen-containing heterocyclic 5- or 6-membered ring which may optionally contain as a further heteroatom an oxygen or sulphur atom (and the ring may optionally be substituted by alkyl with 1 to 4 carbon atoms), or R1 and R2 together with the nitrogen atom represent a 3- to 7-membered ring which may optionally contain as a further heteroatom an oxygen or nitrogen atom [the ring may optionally be substituted by phenyl (C1-4 ) alkyl (this phenyl ring in turn being mono- or disubstituted by halogen atoms or methoxy groups)], or R2 , if R1 represents hydrogen, represents -NH2 , di(C1-2 ) alkylamino, acetonylamino, -NH(C2-3 ) acyl, alkylsulphonyl or alkyloxycarbonyl group with 1 to a carbon atoms in the alkyl chain, a isopropylideneimino group see diagramm : EP0190563,P17,F2 or a heterocyclic 5- or 6-membered ring containing a nitrogen atom and optionally containing as a further heteroatom an oxygen, nitrogen or sulphur atom, R3 , R4 and R5 , which may be identical or different, represent hydrogen or alkyl groups with 1 to 4 carbon atoms, R7 and R8 , which may be identical or different, represent hydroxy, alkoxy with 1 to 4 carbon atoms or alkylthio groups with 1 to 4 carbon atoms, and R6 and R9 , which may be identical or different, represent hydrogen, hydroxy, alkoxy with 1 to 4 carbon atoms or alkylthio groups with 1 to 4 carbon atoms or a group see diagramm : EP0190563,P17,F3 wherein R10 represents hydrogen or alkyl with 1 to 4 carbon atoms and R11 represents alkyl with 1 to 4 carbon atoms any such alkyl group being optionally substituted by a hydroxy, methoxy or furfuryl group or a physiologically acceptable acid addition salt thereof, characterised in that a 3,4-dihydro-12-methyl-mercapto- pyridazino[4',5':3,4]pyrrolo[2,1-a]isoquinoline of general formula II see diagramm : EP0190563,P18,F1 wherein the groups R3 , R4 , R5 , R6 , R7 , R8 and R9 are as hereinbefore defined, is reacted with a compound of general formula III see diagramm : EP0190563,P18,F2 wherein R1 and R2 are as hereinbefore defined, and in that a compound thus obtained is optionally converted, in a manner known per se, into a physiologically acceptable acid addition salt.
    公开号:SU1487811A3
    申请号:SU864005005
    申请日:1986-01-13
    公开日:1989-06-15
    发明作者:Valter Lezel；Otto Roos；Gerd Shnorrenberg；Rikhard Rejkhel；Gelmut Enzinger
    申请人:Boehringer Sohn Ingelheim；
    IPC主号:
    专利说明:

    The invention relates to heterocyclic compounds, in particular, the method of obtaining derivatives of 12 — amino-pyridazino [4 ’, 5’: 3,4] -pyrrolo 2,1-a] isoquinoline of the general formula
    H, allyl, C 3 C cycloalkyl, C, —C ^ alkyl, C ^^ - alkyl substituted by OH,
    OCH 3 , AND (CH 3 ) 2 , cyclohexyl, phenyl, dimethoxyphenyl, pyrrolidino group (it may be substituted by CH 3 ), piperidino group, morpholino group, furyl, pyridino group, thienyl, methyl pyrrolyl; phenyl, unsubstituted or substituted by one halogen, or Κ ^ - ΝΗ ^ or AND (CH E ) 1 , and K - H; or K, and together mean morpholino, pyrrolidinyl, piperazino, substituted by phenylethyl, or their physiologically tolerated compounds with neuroprotective effects, which can be used in medicine. The purpose of the invention is the creation of new more active compounds of the specified class. The synthesis is carried out by the reaction of a compound of the general formula II, where K. 3 is lower alkyl with a compound of the formula ΝΗΚ where K, and K 2 — see above, or its hydrate. The target product is isolated in free form or in the form of a physiologically tolerable acid additive salt. New compounds for neurosis — shield activity surpass muscarine with moderate toxicity. 1 tab.
     511,. „1487811
    3
    1487811
    four
    The invention relates to a method for producing new biologically active chemical compounds, namely derivatives 1 2-aminopyridazino [4 1 ·, 5 :,
    : 3,4] pyrrolo [2,1-a] isoquinoline or their physiologically tolerated acids · but — additive salts with neuroprotective action. This property involves the use of these 10 compounds in medicine.
    The purpose of the invention is to obtain new heterocyclic compounds with improved compared with muscarin activity. 15
    Example 1. 3,4-dihydro — 6,7-dimethoxy-12-C hydrochloride, C-dimethylaminoethyl-amino-pyridazino hydrochloride [4 ’, 5’:
    : 3.4] pyrrolo [2,1-a] isoquinoline.
    8 g of 3,4-dihydro-6,7-dimethoxy-12-20 methyl mercapto-pyridazino [4 ', 5 1 : 3.43 pyrrolo [2,1 — a] isoquinoline and 15 ml (Ν, Ν-dimethylaminoethyl) - amine in 100 ml of dimethylacetamide. heated to boiling point for 2 hours. After cooling to room temperature, the orange-yellow solution is concentrated in vacuo, the oily residue is taken up with methylene chloride, and the extractant. After removal of the solvent, it is purified on a column containing alumina (neutral, degree III), using a mixture of methylene chloride £ 5 and methanol (100: 8) as eluent. The reaction product is dissolved in ethanol and is added as hydrochloride by the addition of ethanolic hydrochloric acid. The yield is 6.6 g (73% 40
    theory), so pl. 271-272 ° C.
    Example 2. 3,4-Dihydro-6,7 dimethoxy-12-hydrazino — pyridazino £ 4 ’, · 5’: 3,4] dirrolo [2,1-a] isoquinoline .45
    5 g of 3,4-dihydro-6,7-dimethoxy-12-methylmercapto pyridazino [4 ', 5 1: 3.4].
    pyrrolo [2,1-a] isoquinoline and 10 ml of hydrazine hydrate in 200 ml of ethanol are heated to boiling point for 2 hours. Upon completion of the reaction, the solution is concentrated in vacuo, the residue is mixed with water, sucked off, and the filter residue is recrystallized from ethanol and ether. 55 compounds are obtained, with a yield of 3.4 g (71% of theory,), m.p. 257-257 ° C.
    Example 3. Hydrochloride 3,4— dihydro-6,7-dnmethoxy-12-dimethyl—
    amino-pyridazino [4 ', 5': 3.4] pyrrolo [2,1-a] isoquinoline.
    5 g of 3,4-dihydro-6,7-dimethoxy-12methylmercapto-pyridazino- [4 *, 5 T :
    : 3,4] pyrrolo [2,1-a] isoquinoline in 100 ml of dimethylformamide is heated
    within 15 h to boiling point. At the end of the reaction the mixture is evaporated, the residue is suspended in methylene chloride and sucked. After dissolving the residue on the filter in hot methanol, the base is transferred to the hydrochloride by adding ethanolic hydrochloric acid and precipitated.
    The yield of the compound is 3.6 g (72% of theory), so pl. 264 ° C
    Analogously to example 3, the following compounds are obtained:
    I. 3,4-Dihydro-6,7-dimethoxy-12-amino-pyridaino [4 *, 5 ’: 3,4] pyrrolo [2,1-a] isoquinoline, mp. 271 ° C, yield 65% of theory.
    Ii. Hydrochloride 3,4-dihydro-6,7 dimethoxy-12-methylaminopyridazino [4 *, 5 ': 3,4] pyrrolo [2,1-a] isoquinoline, mp 260-265 6 C, yield 68% of theory.
    Example 4. The hydrochloride 3,4tsigidro-6,7-dimethoxy-12-dimethylamino-pyridazino [4 ', 5 7 : 3,4] pyrrolo [2,1-a ^ isoquinoline.
    5 g. 3,4-dihydro-6,7-dimethoxy-12methyl mercapto-pyridazino- [4 ', 5 7 :
    : 3,4] pyrrolo [2,1-a] isoquinoline and 20 ml of dimethylamide in 50 ml of dimethyl acetate are heated for 10 hours in an autoclave to 120 ° C. Upon completion of the reaction, the solvent is removed in vacuum, the residue is purified on silica gel (eluent: a mixture of methylene chloride and methanol - 100: 10), the hydrochloride is formed and recrystallized from methanol. Yield 3.1 g (63% of theory), m.p.
    264 ° C.
    Analogously to example 4 receive the following compounds:
    Iii. 3,4-dihydro-6,7 dimethoxy-12-ethylamino-pyridazino hydrochloride [4 ’, 5: 3,4} pyrrolo [2,1-a] isoquinoline yield 3.1 g (63% of theory), m.p.
    273 e C.
    Iv. Hydrochloride 3,4-dihydro-6,7 dimethoxy-12-diethylaminopyridazino [4 ^ 5 * ': 3; 4] pyrrolo [2,1-a] isoquinoline, yield 3.4 g (67% of theory), t, pl. 276 ° C.
    V. Hydrochloride 3,4-dihydro-b, 7- 'Dimethoxy — 12 — cyclopropyl-aminopyridazino [4', 5 7 : 3,4] pyrrolo [2,1-c] isohi! ΛΒ ζ'Β! one
    nolina, yield 2, Lg (46% of theory), so pl. 258 ° C.
    Example 5. Hydrochloride 3,4-, dihydro-6,7-dimethoxy-12-morpholinopiridazino [4 ’, 5’: 3,4] pyrrolo [2,1-a] isoquinoline,
    5 g of 3,4-dihydro-6,7-dimethoxyI2 — methyl mercapto-pyridazino [4 *, 5 *:
    : 3,4] pyrrolo [2,1-a] isoquinoline and 20 ml of morpholine in 100 ml of dimethyl - acetamide are heated for 1.5 hours to boiling point. At the end of the reaction, it is concentrated in vacuo, the residue is triturated in methylene chloride and 15 hours of suction. The reaction product is dissolved in a mixture of methylene chloride and methanol, transferred to the hydrochloride salt by the addition of ethanolic hydrochloric acid and crystallized. 20
    The yield of the connection is 3.5 g (63% of the spriti), so pl. 267 ° C.
    Analogously to example 5 receive the following compounds:
    Vi. 3,4-dihydro-6,7-25 hydrochloride
    dimethoxy-I2-isopropylamino-pyridazino [4 ', 5 1 : 3,4] pyrrolo [2,1-a] isoquinoline, yield 3.0 g (57% of theories) 5
    m.p. 238 ° C.
    VII. 3,4-dihydro-6,7-30 dimethoxy-12-butylaminopyropidazino hydrochloride
    [4 ', 5 7 : 3,4] pyrrolo [2,1-a] isoquinoline, yield 4.2 g (78% of theory), mp,
    257 e C.
    Viii. 3,4-dihydro-6,7 dimethoxy-12-Ν,-dimethylhydrazinopyridazino [4 ', 5 °: 3,4] pyrrolo [2,1-a] isoquinoline hydrochloride, yield 4.5 g (87% of theory), m.p. 256-257 ° C.
    Ix. 3,4-Digdro-b, 7-dd dimethoxy-12- (2-methoxyethyl) -aminopyridazino [4 ', 5 7 : 3,4] pyrrolo [2,1-a] isoquinoline hydrochloride, yield 3.6 g ( 67% of theory), so pl. 252 ° C.
    X. 3,4-dihydro-6,7 dimethoxy-12 [2- (3,4-dimethoxyphenyl) ethyl] amino-pyridazino [4 7 , 5 ^ 3,4] pyrrolo [2,1-a] isoquinoline hydrochloride , yield 5.5 g (78% of theory), so pl. 257 ° C.
    Xi. 3,4-dihydro-6,7 dimethoxy-12-cyclopentylamino-pyrida-zino hydrochloride [4 7 , 5 ': 3.4] pyrrolo [2,1-a] isoquinoline, yield 3.1 g (56% of theory) ,
    m.p. 265 ° C.
    Xii. 3,4-dihydro-6,7 dimethoxy — 12-cyclohexylmethyl — pyri-dazino hydrochloride (.4 ', 5': 3.4] pyrrolo [2, 1 — a] iso-quinoline, yield 5.2 g (87% theory), mp. 262 e C.
    XIIT. Hydrochloride 3,4-dihydro-6,7 dimethoxy — 1 2— [2— [2- (1-methyl) -pyrrolidine) ethyl] amino-pyridazino [4 , five':
    : 3, A1pyrrolo [2,1-a] isoquinoline, yield 4.3 g (69% of theory), m.p. 256258 ° C.
    Xiv. 3,4-dihydro-6,7 dimethoxy-12 G2- (1-piperidinyl) ethyl) hydrochloride
    amino-pyridazino [4 ', 5 7 : 3,4] pyrrolo (2,1-a) isoquinoline, yield 3.3 g (53% of theory), mp 248-251' C.
    Xv. 3,4-dihydro-6,7 dimethoxy-12-pyrrolidinyl-pyridazino hydrochloride
    [4 ‘, 5’: 3,4] pyrrolo [2, 1-a] isoquinoline, yield 3.1 g (59% of theory) ", mp. 277-278 ° C
    Xvi. 3,4-dihydro-6,7 dimethoxy-12-n-propylamino-pyridazino hydrochloride [4 7 , 5 ': 3,4] pyrrolo [2,1-a] isoquinoline, yield 3.7 g (72% of theory), m.p. 258 ° C.
    XVII. Hydrochloride 12-allylamino-3,4-dihydro-b, 7-dimethoxy-pyridazino [4 ', 5': 3,4] pyrrolo [2,1-a] isoquino> lin, yield 2.7 g (53% of theory), m.p. 263 C.
    XVIII. 3,4-dihydro hydrochloride—
    6.7 — dimethoxy — 12— (3-dimethylaminopropyls) -amino-pyridazino (4 ’, 5 ^: 3,4) pyrrolo [2,1-a] isoquinoline,
    2.4 g (43% of theory), so pl. 247-249 ° C.
    XIX. 3,4-Dihydro-6,7 dimethoxy — 1 2- [2- (1-morpholinyl) ethyl] -amino-pyridazino [4 ', 5 *: 3.4] pyrrolo [2,1-a) isoquinoline hydrochloride, yield 3.4 g (54% of theory), m.p. 273-274 ° C.
    . Xx. Hydrochloride 3,4-dihydro-6,7 dimethoxy-12 — n-pentylamino ~ pyridaei — no— [4 1 , 5 ': 3,4] pyrrolo [2,1 — a] isoquine — ling, yield 4.9 g (87% of theory), so pl. 259-261 ° C.
    XXI. 3,4-dihydro-6,7 dimethoxy — 12 — cyclohexylamino-pyri-dazino hydrochloride (4 7 , 5 1 : 3,4] pyrrolo [2,1 — a] iso-quinoline, yield 3.8 g (66% of theory ), mp. 253 a C.
    Xxii. Hydrochloride 3,4 — dihydro-6,7 — dimethoxy — 12— [4— (2-phenylethyl) -pippe — razinil] —pyridazino [4 ', 5': 3,4] pyrrolo [2,1-a ] isoquinoline, yield 3.8 g (53% of theory), so pl. 264 ° C.
    Xxiii. The hydrochloride is 3,4-dihydro6.7 — dimethoxy — 12 — furfurylamino-pyri-. dazino [4 *, 5 ’: 3,4] pyrrolo [2,1-a] isoquinoline, yield 3.2 g (56% of theory), m.p. 243-246 ° C.
    Xxiv. 3,4-dihydro-6,7 dimethoxy — 12– (3-methoxypropylamino) hydrochloride 8
    pyridaino [4 5 ’: 3,4) pyrrolo [2,1-a) isoquinoline, yield 3.6 g (65% of theory), mp. 269-270 “C.
    Xxv. Hydrochloride 3 ^ -dihydro-b ^ dimethoxy-! 2-isopentylamino-pyridazi · * but but [4 ’’, 5 ’: 3,4) lirrolo [2,1-a] isoquinol, yield 3.2 g (58% of theory).
    XXVI, 3,4-dihydro6.7-dimethoxy-1 2 [2- (1.-pyrrolidinyl) ethyl] amino-pyridazino hydrochloride (4 ', 5': 3,4] pyrrolo [2,1-a) isoquinoline , yield 3.3 g (55% of theory), mp »275276 ° C.
    Xxvii. 3,4-Dihydro6.7-dimethoxy-12- (2-hydroxyethyl) aminopyridazino [4 ', 5': 3,4] pyrrolo [2,1-a] isoquinoline hydrochloride, yield 4.2 g (80% of theory ), so pl. 259 ° C.
    Example 6. Hydrochloride 3,4 “dihydro-6,7-dimethoxy-12-anilinopyridazino- (4’, 5 ’: 3,4] pyrrolo [2,1-a] 'isoquinoline.
    5 g of 3,4-dihydro-6,7-dimethoxy-12methylmercapto-pyridazino [4, 5 ’: 3,4] pyrroloΐ2.1 — a) isoquinoline in 50 ml of aniline in a nitrogen atmosphere for 6 hours to boiling point. The excess aniline is separated in vacuum, the residue is triturated in methylene chloride, sucked off and recrystallized from a mixture of methanol and methylene chloride, and the yield is 3.0 g (53% of theory), so pl. 287-288 ° C.
    Analogously to example 6 receive the following compounds:
    Xxviii. 3,4-Digi)], ro-6,7 ”Dimethoxy12- (4-fluoroanilino) -pyridazino [4’,
    5 1 ,: 3,4] pyrrolo [2,1-a] isoquinoline, yield 4.0 g (67% of theory), m.p. 301— 302 ° С.
    XXIX. 3,4-dihydro-6,7 dimethoxy-12- (2- (4-pyridinyl) ethyl) aminopyridazino hydrochloride (4 ', 5': 3,43 pyrrolo [2,1 ~ a] isoquinoline, yield 4, 1 g
    (70% of theory), so pl. 235-238 ° C.
    Xxx. 3,4-dihydro-6,7 dimethoxy ~ (1 2- [2- (2-pyridinyl) ethyl) amino-pyridazino [4 ', 5 1 ,: 3.43 pyrrolo [2, Ia] isoquinoline, yield 3.7 g (62% of theory), so pl. 239-24I e C.
    Xxxi. 3,4-dihydro6.7-dimethoxy-I2- [2- (3-thieno) -ethyl] amino-pyridazino [4 ', 5', 3,4] pyrrolo [2,1-a ^ isoquinoline hydrochloride, yield 4.0 g (65% of theory), so pl. 257-258 ° C.
    Xxxx. 3,4-dihydro6.7-dimethoxy ~ 12-2- [3- [3- (1-methyl) pyrrolyl] -ethyl) amino-pyridazino hydrochloride [4 ’,
    3781 I
    5 1 : 3,4] pyrrolo [2,1-a} and eokhinolnna, yield 3.6 g (61% of theory), so pl. 256-258 ° C.
    5 XXXIII. 3,4-dihydro-6,7-dimethoxy-127 hydrobutylaminopyridazino [4 ', 5': 3,4] pyrrolo [2,1-a] isoquinoline hydrochloride, m.p. 250 ° C.
    Xxxiv. 3,4-dihydro 10 6,7-dimethoxy-12-benzylamino-pyridazino hydrochloride [4 ’, 5 ': 3,4} pyrrolo (2,1-a) from quinoline, mp. 257 ° С.
    Biological tests (neuroprotective effect).
    15 Homogenizate from the ammonium horns of the rat brain was incubated with pirezepin tritium and radio ligands were displaced by addition of the test substance. The displacement of radioligands by the testimony20 of the degree of affinity of a substance with a muscarinol-oline-energy receptor, in particular M1. Affinity is indicated by apparent dissociation konsatnta (CD), which is indicated in
    25 nmol / l. By compound activity
    compared with muscarinic (tetrahydro — 4 4-hydroxy-M, K, L-5-tetralitin-2-furanmethanammonium) - cardio and neuroprotective agent.
    thirty
    The results of the experiment are as follows:
    Test compound nmol / l
    example or compound
    35 No.
    Example 3 434 Example 5 650 XIII 531 40 Xv 235 XVIII 1056 XXIII 4160 III 879 XXXIV 935 45 VI 1450 Ix 1280 X 930 Xi 780 ΧΙΙΪ 2100 50 XVIII 3200 XVIII 1750 XXI 1810 XXII 1250 XXIII 1090 55 Xxvii 780 XXVIII 850 , XxixTrading product 1640 muscarine 10900
    about
    14878) ι
    ! ABOUT
    Comparison of the data suggests that the proposed compounds exhibit a significantly greater affinity for the M1 receptors (in the brain) than the commercial product muscarin.
    The proposed compounds are classified as medium toxic substances.
    权利要求:
    Claims (1)
    [1]
    Formula of invention
    δΚ 3
    The method of obtaining derivatives of 12 * amino-pyridazino [4, 5: 3,41-pyrrolo [2; 1-a] isoquinoline, the general formula
    χΚι
    15
    subjected to interaction with the compound of the General formula
    ΝΗ · "- Ηι
    where K, and K g have the indicated values, or his. hydrate followed by the division of the target product in the free form or in the form of a physiologically tolerable acid addition salt.
    Priority featured:
    20
    where K g and G g ,. which may be the same or different, means hydrogen, allyl, C 3 —C 4 -cycloalkyl, unsubstituted C, -Su-alkyl, C ^ -C 3 -alkyl, substituted by hydroxyl, Methoxy * 25 scrap, dimethylamino, cyclohexyl, phenyl, dimethoxyphenyl, pyrrolidino, unsubstituted or substituted by methyl, piperidinogroup, morpholino, furyl, pyridinogroup, thienyl, methylpyrroli · scrap; phenyl, unsubstituted or substituted * * by one halogen, or K ^ -amino or dimethylamino, and K 1 - hydrogen, or K, K Λ, together with the nitrogen atom, means the morpholino group ,. pyrrolidinyl, piperazino, substituted phenyl (ethyl,
    ! or their physiologically tolerated acid-addition salts, which are different from the fact that the compound is a common form, the mules
    01/14/85 - with and K 2 are the same or different and mean hydrogen, C, C ^ -alkyl, C 1 -C 3 -alkyl substituted by hydroxyl, methoxy, dimethylamino, cyclohexyl, phenyl or dimethoxyphenyl, phenyl, unsubstituted or substituted by one halogen or and K together with the nitrogen atom means the morpholino group, pyrrolidinyl
    I 3.07.85 - at K, and they are the same or different and mean C 3 -C ^ cycloalkyl, allyl, C t –C 3 -alkyl, substituted by pyrrolidino group, not substituted or methyl, piperidine, morpholino, · furyl, pyridino, thienyl or methylpyrrolyl, or K 2 - amino or dimethylamino, and E 1 - hydrogen, or Cz and K. together with the nitrogen atom means piperazino, substituted by phenylethyl.
    类似技术:
    公开号 | 公开日 | 专利标题
    KR100226184B1|1999-10-15|Imidazo|quinolin-4-amines and process thereof
    RU2124510C1|1999-01-10|Aminoquinolone derivatives substituted by phenyl or heteroaromatic group
    RU2100357C1|1997-12-27|Heteroarylamines or their pharmaceutically acceptable salts and pharmaceutical composition based on thereof
    EP0691339A1|1996-01-10|Amine derivatives of 1,3-dihydro-2H-pyrrolo|pyridin-2-ones and oxazolo|pyridin-2|-ones, their process of preparation and pharmaceutical compositions containing them
    DE3835842A1|1990-04-26|INDOLOCARBAZOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
    SU1487811A3|1989-06-15|Method of producing derivatives of 12-amino-pyridazino-/4',5':3,4/-pyrrolo-/2,1-a/isoquinoline or their physiologically allowable acid-additive salts
    Rivalle et al.1983|Antitumor amino-substituted pyrido [3', 4': 4, 5] pyrrolo [2, 3-g] isoquinolines and pyrido [4, 3-b] carbazole derivatives: synthesis and evaluation of compounds resulting from new side chain and heterocycle modifications
    US4694085A|1987-09-15|5,6-dihydro-pyrrolo[2,1-a]isoquinolines and the preparation thereof
    US4996213A|1991-02-26|Derivatives of 4-amino 3-carboxy naphthyridines and their pharmaceutical compositions
    AU630122B2|1992-10-22|N-arylation of isatins
    SU1609449A3|1990-11-23|Method of producing indenthiazol
    US3600393A|1971-08-17|Dialkylamino alkylamino pyrazolo | quinolines
    KR860001819B1|1986-10-24|Process for the preparing of hexahydro-trans-pyridoindole derivatives
    US3966760A|1976-06-29|2-Substituted-5,6-dimethoxyindazoles
    Hermecz et al.1984|Nitrogen-bridgehead compounds; 401. Cyclization in phosphoryl chloride-polyphosphoric acid mixture
    US4297357A|1981-10-27|N-Phenethylacetamide compounds and process for preparation thereof
    US3654275A|1972-04-04|Quinoxalinecarboxamide antiinflammatory agents
    IE43651B1|1981-04-22|N-/1-/|-alkyl/ 4-piperidinyl/-n-phenylalkylamides
    US4062953A|1977-12-13|Various 2-substituted-1H-benz[de]isoquinoline-1,3|-diones
    SU845778A3|1981-07-07|Method of preparing 5-puenyl-1h-banzazepins or their salts
    US6162822A|2000-12-19|Bisimide compounds
    EP0393109B1|1994-03-23|Novel 2,3-thiomorpholinedione-2-oxime derivatives, pharmaceutical compositions containing them and process for preparing same
    US4070465A|1978-01-24|Various 2-|-1H-benz [de]isoquinoline-1,3 | -diones
    US3573286A|1971-03-30|Pyridoxal derivatives and production thereof
    Glamkowski et al.1979|Synthesis of 1, 2‐dihydroindolo [1, 7‐AB][1, 5] benzodiazepines and related structures. A new heterocyclic ring system
    同族专利:
    公开号 | 公开日
    ES8707533A1|1987-08-01|
    AU5228486A|1986-07-17|
    NZ214815A|1989-06-28|
    NO162468B|1989-09-25|
    AU591646B2|1989-12-14|
    NO860091L|1986-07-15|
    YU4286A|1988-08-31|
    PH27043A|1993-02-01|
    HUT40129A|1986-11-28|
    IE860085L|1986-07-14|
    EP0190563A1|1986-08-13|
    FI82467C|1991-03-11|
    JPS61204186A|1986-09-10|
    KR860005819A|1986-08-13|
    IE58701B1|1993-11-03|
    PL257472A1|1987-06-15|
    FI860127A|1986-07-15|
    NO162468C|1990-01-10|
    DK14686D0|1986-01-13|
    GR860070B|1986-05-14|
    FI860127A0|1986-01-13|
    PT81828A|1986-02-01|
    YU45758B|1992-07-20|
    PT81828B|1988-05-27|
    DK14686A|1986-07-15|
    HU196203B|1988-10-28|
    CS254990B2|1988-02-15|
    KR930003074B1|1993-04-17|
    DK166882B1|1993-07-26|
    FI82467B|1990-11-30|
    US5614516A|1997-03-25|
    CS26886A2|1987-06-11|
    DE3664772D1|1989-09-07|
    CA1256432A|1989-06-27|
    EP0190563B1|1989-08-02|
    PL147961B1|1989-08-31|
    HK97393A|1993-09-24|
    JPH0764844B2|1995-07-12|
    ES550824A0|1987-08-01|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    FR7348M|1968-02-26|1969-10-13|
    FR2510998B1|1981-08-07|1986-01-10|Sanofi Sa|NOVEL AMINO DERIVATIVES OF PYRIDAZINE, PROCESS FOR THEIR PREPARATION AND DRINKING ACTS THEREOF|
    FR2511366B1|1981-08-11|1984-12-14|Sanofi Sa|
    FR2540113B1|1983-01-27|1985-05-17|Sanofi Sa|
    DE3401018A1|1984-01-13|1985-07-18|Boehringer Ingelheim KG, 6507 Ingelheim|METHOD FOR PRODUCING 5,6-DIHYDRO-PYRROLO ISOCHINOLINES|
    JP3909583B2|2001-08-27|2007-04-25|セイコーエプソン株式会社|Manufacturing method of electro-optical device|JPH0535356B2|1986-04-25|1993-05-26|Sumitomo Heavy Industries|
    DE3619099A1|1986-06-06|1987-12-10|Boehringer Ingelheim Kg|USE OF 12-AMINO-PYRRIDAZINOPYRROLO--ISOCHINOLINES AS A CARDIO- AND NEUROPROTECTIVE AGENT|
    US4985560A|1990-01-12|1991-01-15|American Home Products Corporation|Pyridazinoindolizines|
    JP3468520B2|1992-06-22|2003-11-17|ベーリンガーインゲルハイムコマンディトゲゼルシャフト|9-Amino-pyridazino [4 ', 5': 3,4] pyrrolo [2,1-a] isoquinoline and use of the compound in the manufacture of pharmaceutical preparations|
    DE4343649A1|1993-12-21|1995-06-22|Boehringer Ingelheim Kg|Novel pyridazino [4 ', 5': 3,4] pyrrolo [2,1-a] isoquinolines and their use in the preparation of pharmaceutical preparations|
    KR100429356B1|2001-04-23|2004-05-31|조수동|Isoquinoline derivatives with multi-drug resistance modulating activity and process for the preparation of the same|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    DE19853500941|DE3500941A1|1985-01-14|1985-01-14|Novel 12-aminopyridazino[4',5':3,4]pyrrolo[2,1-a]isoquinolines, a process for their preparation, and their use|
    DE19853525048|DE3525048A1|1985-07-13|1985-07-13|Novel 12-aminopyridazino[4',5':3,4]pyrrolo[2,1-a]isoquinolines, processes for their preparation, and their use|
    [返回顶部]